Coverage
-
August 08, 2013
Pfizer Inc. unit Wyeth Pharmaceuticals Inc. will pay $13.5 million in attorneys' fees for a drug-related class action settlement after a New York federal judge on Wednesday ruled that the stockholder who objected to the payout lacked standing.
4 other articles on this case.
View all »